Christopher R Gordon

CIK 1432313 · last filed 2024-08-05

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$13.11B

Companies

5

Total Filings

34

Lifetime Open-Market Net

-$3.52B

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
Cerevel Therapeutics Holdings, Inc. (CERE) Delisted	Director	65,693,524	$44.96	$2.95B	$125.00M	4	2024-06-07
Cerevel Therapeutics Holdings, Inc. (CEREW) Delisted	Director	60,632,356	$18.07	$1.10B	$103.42M	3	2021-06-14
ACHC	Director	12,328	$24.60	$303.3K	-$366.54M	8	2018-05-07
Q	Director	9,944,017	$150.65	$1.50B	-$901.86M	10	2015-08-07
HCA	Director	30,003,156	$387.18	$11.62B	-$2.48B	8	2013-11-05

Recent Filings · Page 4 of 4

34 filings

Form 4 transactions across all companies, newest first.

Filed	Symbol	Action	Net Shares	Net $	Link
2012-12-18	HCA	Sell (S)	−15,033,063	-$496.09M	EDGAR
2012-12-12	HCA	Other (J)	−253,178	$0	EDGAR
2011-03-17	HCA	Sell (S)	−15,619,633	-$451.60M	EDGAR
2011-03-11	HCA	Other (J)	−174,865	$0	EDGAR

Showing 31–34 of 34

Prev Page 4 of 4

Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.